Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Mazzaferro

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paperPieter Evenepoel, Patrick D'Haese, Justine Bacchetta, et al.
Journal of Nephrology|March 16, 2024
Residents' satisfaction and suggestions to improve nephrology residency in Italy, and comparison with the organization in other European countriesAdolfo Marco Perrotta, Silverio Rotondi, Maria Amicone, et al.
Blood Purification|June 1, 2011
Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortalityDiego Brancaccio, Mario Cozzolino, Giuseppe Cannella, et al.
Clinical Kidney Journal|September 29, 2015
Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)Vincent Brandenburg, Teresa Adragao, Bastiaan van Dam, et al.
Blood Purification|October 4, 2014
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohortMario Cozzolino, Piergiorgio Messa, Diego Brancaccio, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 16, 2019
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapySilvia Lai, Maurizio Muscaritoli, Paola Andreozzi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2012
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO SurveyMario Cozzolino, Diego Brancaccio, Giuseppe Cannella, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2009
Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patientsLuigi Francesco Morrone, Sandro Mazzaferro, Domenico Russo, et al.
Journal of Medical Economics|June 19, 2012
Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO studyDaniela Paola Roggeri, Sandro Mazzaferro, Diego Brancaccio, et al.
Nutrients|February 25, 2023
Association between Cognitive Impairment and Malnutrition in Hemodialysis Patients: Two Sides of the Same CoinSilverio Rotondi, Lida Tartaglione, Marzia Pasquali, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paperPieter Evenepoel, Patrick D'Haese, Justine Bacchetta, et al.
Journal of Nephrology|March 16, 2024
Residents' satisfaction and suggestions to improve nephrology residency in Italy, and comparison with the organization in other European countriesAdolfo Marco Perrotta, Silverio Rotondi, Maria Amicone, et al.
Blood Purification|June 1, 2011
Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortalityDiego Brancaccio, Mario Cozzolino, Giuseppe Cannella, et al.
Clinical Kidney Journal|September 29, 2015
Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)Vincent Brandenburg, Teresa Adragao, Bastiaan van Dam, et al.
Blood Purification|October 4, 2014
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohortMario Cozzolino, Piergiorgio Messa, Diego Brancaccio, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 16, 2019
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapySilvia Lai, Maurizio Muscaritoli, Paola Andreozzi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2012
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO SurveyMario Cozzolino, Diego Brancaccio, Giuseppe Cannella, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2009
Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patientsLuigi Francesco Morrone, Sandro Mazzaferro, Domenico Russo, et al.
Journal of Medical Economics|June 19, 2012
Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO studyDaniela Paola Roggeri, Sandro Mazzaferro, Diego Brancaccio, et al.
Nutrients|February 25, 2023
Association between Cognitive Impairment and Malnutrition in Hemodialysis Patients: Two Sides of the Same CoinSilverio Rotondi, Lida Tartaglione, Marzia Pasquali, et al.
Pageof 13